Home ›
Trademark Categories ›
Pharmaceuticals ›
2003 ›
AM ›
AMPLIZONE
Trademark search for:
AMPLIZONE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2003-08-04 — Application filed
2004-01-17 — Assigned to examiner
2004-01-22 — Examiners amendment e-mailed
2004-01-23 — Approved for pub - principal register
2004-02-25 — Notice of publication
2004-03-16 — Published for opposition
2004-03-29 — Paper received
2004-06-08 — Noa mailed - sou required from applicant
2004-12-07 — Sou extension 1 filed
2004-12-07 — Sou extension 1 granted
2004-12-13 — Paper received
2005-06-08 — Sou extension 2 filed
2005-06-10 — Paper received
2005-06-21 — Sou extension 2 granted
2005-10-10 — Teas revoke/app/change addr of atty/dom rep received
2005-10-10 — Attorney/dom.rep.revoked and/or appointed
2005-12-07 — Paper received
2005-12-07 — Sou extension 3 filed
2005-12-07 — Sou extension 3 granted
2006-02-07 — Assigned to examiner
2006-06-06 — Sou extension 4 filed
2006-06-09 — Paper received
2006-07-11 — Sou extension 4 granted
2006-12-08 — Paper received
2006-12-08 — Sou extension 5 filed
2007-02-13 — Sou extension 5 granted
2007-05-23 — Assigned to examiner
2007-06-09 — Final status recorded
2008-01-15 — Application abandoned
2008-01-15 — Application abandoned
Owner Information
AmpliMed Corporaton
Tucson , AZ
AmpliMed Corporaton
Tucson , AZ
Correspondent
LANCE A TERMES AMPLIMED CORPORATION 4380 N CAMPBELL AVE STE 205 TUCSON, AZ 85718 UNITED STATES
Filing Details
Filing Date:
2003-08-04
Status Date:
2007-06-09
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.